- Home
- RNAZ vs STAF Comparison
RNAZ vs STAF Comparison
Compare RNAZ & STAF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RNAZ
- STAF
- Stock Information
- Founded
- RNAZ 2016
- STAF 2009
- Country
- RNAZ United States
- STAF United States
- Employees
- RNAZ N/A
- STAF N/A
- Industry
- RNAZ Biotechnology: Pharmaceutical Preparations
- STAF Professional Services
- Sector
- RNAZ Health Care
- STAF Consumer Discretionary
- Exchange
- RNAZ Nasdaq
- STAF Nasdaq
- Market Cap
- RNAZ 4.9M
- STAF 5.2M
- IPO Year
- RNAZ 2021
- STAF N/A
- Fundamental
- Price
- RNAZ $3.35
- STAF $3.37
- Analyst Decision
- RNAZ Strong Buy
- STAF
- Analyst Count
- RNAZ 1
- STAF 0
- Target Price
- RNAZ $20.00
- STAF N/A
- AVG Volume (30 Days)
- RNAZ 143.7K
- STAF 1.1M
- Earning Date
- RNAZ 11-14-2024
- STAF 02-11-2025
- Dividend Yield
- RNAZ N/A
- STAF N/A
- EPS Growth
- RNAZ N/A
- STAF N/A
- EPS
- RNAZ N/A
- STAF N/A
- Revenue
- RNAZ N/A
- STAF $176,819,000.00
- Revenue This Year
- RNAZ N/A
- STAF $1.94
- Revenue Next Year
- RNAZ N/A
- STAF $8.38
- P/E Ratio
- RNAZ N/A
- STAF N/A
- Revenue Growth
- RNAZ N/A
- STAF 13.64
- 52 Week Low
- RNAZ $2.66
- STAF $1.08
- 52 Week High
- RNAZ $66.33
- STAF $5.69
- Technical
- Relative Strength Index (RSI)
- RNAZ 30.32
- STAF 70.22
- Support Level
- RNAZ $2.90
- STAF $2.65
- Resistance Level
- RNAZ $3.50
- STAF $3.73
- Average True Range (ATR)
- RNAZ 0.42
- STAF 0.32
- MACD
- RNAZ 0.31
- STAF 0.11
- Stochastic Oscillator
- RNAZ 50.74
- STAF 78.70
About RNAZ TransCode Therapeutics Inc.
TransCode Therapeutics Inc is a clinical-stage oncology company focused on treating metastatic disease. It is committed to defeating cancer through the intelligent design and effective delivery of RNA therapeutics based on its proprietary TTX nanoparticle platform. The company's lead therapeutic candidate, TTX-MC138, is focused on treating metastatic tumors which overexpress microRNA-10b, a unique, well-documented biomarker of metastasis. In addition, TransCode is developing a portfolio of first-in-class RNA therapeutic candidates designed to overcome the challenges of RNA delivery and thus unlock therapeutic access to a variety of novel genetic targets that could be relevant to treating a variety of cancers.
About STAF Staffing 360 Solutions Inc. (DE)
Staffing 360 Solutions Inc operates in the international staffing sector. It is engaged in the execution of an international buy-integrate-build process through the acquisition of domestic and international staffing organizations. The company operates through three Business Streams: Professional Staffing, Commercial Staffing, and Employer of Record. It primarily supports accounting and finance, information technology, engineering, administration, and commercial disciplines.